HRH Duke of Edinburgh, 10 June 1921 to 9 April 2021 Read more

Publication - Advice and guidance

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol

Published: 24 Mar 2021

This protocol is for the supply and administration of COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech to individuals in accordance with the national COVID-19 vaccination programme.

33 page PDF

567.0 kB

33 page PDF

567.0 kB

Contents
COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol
5. Clinical condition or situation to which this Protocol applies

33 page PDF

567.0 kB

5. Clinical condition or situation to which this Protocol applies

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech is indicated for active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in accordance with Scottish Government COVID-19 immunisation programme and recommendations given in Chapter 14a of the Immunisation Against Infectious Disease: the 'Green Book' COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk) and Scottish Government CMO letters relating to COVID-19 vaccination.


Contact

Email: Covid19VaccinePolicyMailbox@gov.scot